Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Therapeutic effect of an MRGPRX2/MRGPRB2 antagonist on LL-37-induced rosacea-like inflammation in mice.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: September 04, 2025
Mas-Related G-Protein Coupled Receptor-X2 and Chemokine (C-C Motif) Ligand 2 Correlate With Disease Activity Among Treatment-Naïve Chinese Patients With Chronic Spontaneous Urticaria.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: May 17, 2024
Beyond the classic players: Mas-related G protein-coupled receptor member X2 role in pruritus and skin diseases.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: April 02, 2024
MRGPRX2 antagonist GE1111 attenuated DNFB-induced atopic dermatitis in mice by reducing inflammatory cytokines and restoring skin integrity.
Journal: Frontiers in immunology
Published: March 26, 2024
MRGPRB2/X2 and the analogous effects of its agonist and antagonist in DSS-induced colitis in mice.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 23, 2023
Novel small molecule MRGPRX2 antagonists inhibit a murine model of allergic reaction.
Journal: The Journal of allergy and clinical immunology
Published: June 07, 2022
P17 induces chemotaxis and differentiation of monocytes via MRGPRX2-mediated mast cell-line activation.
Journal: The Journal of allergy and clinical immunology
Published: August 15, 2020
Protective Effect of Genistein against Compound 48/80 Induced Anaphylactoid Shock via Inhibiting MAS Related G Protein-Coupled Receptor X2 (MRGPRX2).
Journal: Molecules (Basel, Switzerland)
Published: January 27, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026